INVO Fertility, Inc.
IVF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.00 | -0.00 |
| FCF Yield | -68.37% | -493.65% | -575.08% | -23.14% |
| EV / EBITDA | -4.33 | -2.46 | -0.51 | -3.78 |
| Quality | ||||
| ROIC | -15.03% | -27.48% | -91.72% | -11.16% |
| Gross Margin | 35.82% | 41.32% | 36.18% | 43.21% |
| Cash Conversion Ratio | 0.67 | 0.33 | 0.20 | 0.17 |
| Growth | ||||
| Revenue 3-Year CAGR | 53.58% | 77.82% | 87.04% | 99.54% |
| Free Cash Flow Growth | -3.37% | 51.51% | -411.33% | -8.65% |
| Safety | ||||
| Net Debt / EBITDA | -2.59 | -2.33 | -0.47 | -2.85 |
| Interest Coverage | -11.22 | -13.51 | -54.96 | -17.15 |
| Efficiency | ||||
| Inventory Turnover | 5.88 | 5.14 | 4.83 | 4.36 |
| Cash Conversion Cycle | -161.48 | -154.05 | -383.99 | -507.13 |